SCORPION THERAPEUTICS
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.
SCORPION THERAPEUTICS
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.scorpiontx.com
Total Employee:
51+
Status:
Active
Contact:
(212) 841-1015
Email Addresses:
[email protected]
Total Funding:
270 M USD
Technology used in webpage:
ReCAPTCHA Mimecast DocuSign SparkPost
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Boxer Capital
Boxer Capital investment in Series B - Scorpion Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Scorpion Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Scorpion Therapeutics
OrbiMed
OrbiMed investment in Series B - Scorpion Therapeutics
Vida Ventures
Vida Ventures investment in Series B - Scorpion Therapeutics
Nextech Invest
Nextech Invest investment in Series B - Scorpion Therapeutics
Omega Funds
Omega Funds investment in Series B - Scorpion Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Scorpion Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series B - Scorpion Therapeutics
Invus
Invus investment in Series B - Scorpion Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-22 | Scorpion Therapeutics Announces Appointment of Brian Piper as Chief Financial Officer |
Official Site Inspections
http://www.scorpiontx.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.84 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Scorpion Therapeutics"
Scorpion Therapeutics - Crunchbase Company Profile …
Organization. Scorpion Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number (212) 841-1015; Scorpion …See details»
Scorpion Therapeutics
Oct 26, 2020 Cancer has always been an elusive foe, capable of evolving to evade our attempts at eradication. From genetic mutations and chromosomal instabilities to changes in key enzymes and proteins, the drivers that tumor …See details»
About – Scorpion Therapeutics
Our fully integrated discovery platform is built upon the most advanced technologies available for drug discovery, small molecule design, and target identification that we believe will enable us …See details»
Scorpion Therapeutics Announces $150 Million Series C Financing …
For more information, visit www.scorpiontx.com. About Frazier Life Sciences. Frazier Life Sciences invests globally in private and publicly-traded companies that discover, develop, and …See details»
Scorpion Therapeutics - LinkedIn
Scorpion is a pioneering clinical-stage oncology company redefining the frontier of precision medicine to deliver optimized and transformational therapies for larger populations of patients with ...See details»
Scorpion Therapeutics - Overview, News & Similar companies
Jul 21, 2024 Who is Scorpion Therapeutics. Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting …See details»
Scorpion Therapeutics Appoints Adam Friedman, M.D., Ph.D
Jan 4, 2024 Dr. Friedman, who joined as part of Scorpion’s founding team and most recently served as President, Corporate Strategy and Business Development, succeeds Axel Hoos, …See details»
Scorpion Therapeutics Announces $150 Million Series C Financing …
BOSTON, July 16, 2024--Scorpion Therapeutics, Inc. ("Scorpion"), a pioneering clinical-stage oncology company dedicated to transforming the lives of cancer patients by redefining the …See details»
Scorpion Therapeutics, Inc. (Scorpion Therapeutics, Inc.) - 药物管 …
Abstract PI3Kα is highly mutated in cancer resulting in hyperactivation of lipid kinase activity and downstream AKT signaling. H1047 is the most common site of oncogenic mutation and occurs …See details»
Scorpion Therapeutics Announces Appointment of …
Nov 22, 2021 Media Contact: Ravi Moorthy Scorpion Therapeutics [email protected]. Investor Contact: Hannah Deresiewicz Stern Investor Relations, Inc. [email protected]. Site Navigation.See details»
Explore Careers - Scorpion Therapeutics
APPLY AT [email protected]. #LI-RC1 Paralegal Boston, MA. Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent …See details»
Scorpion Therapeutics Launches with $108 Million to Advance …
Oct 26, 2020 Dr. Guzman-Perez joins Scorpion from Amgen’s research organization, where he served as executive director, head of medicinal chemistry, and was responsible for the small …See details»
Scorpion Therapeutics and Pierre Fabre Announce Collaboration …
For more information, visit www.scorpiontx.com. About Pierre Fabre. Pierre Fabre is a leading French medical and beauty care company with 4 decades of experience in innovation, …See details»
Scorpion Therapeutics Announces $150 Million Series C Financing …
Jul 16, 2024 For more information, visit www.scorpiontx.com. About Frazier Life Sciences. Frazier Life Sciences invests globally in private and publicly-traded companies that discover, …See details»
Scorpion Therapeutics Appoints Adam Friedman, M.D., Ph.D., as …
Jan 4, 2024 Friedman, who joined as part of Scorpion’s founding team and most recently served as President, Corporate Strategy and Business Development, succeeds Axel Hoos, M.D., …See details»
Scorpion Therapeutics Announces First Patient Dosed in Phase 1/2 ...
May 2, 2023 STX-478 has a potential best-in-class profile and is Scorpion’s first program to enter clinical development ---- Initial Phase 1 safety, pharmacokinetic and pharmacodynamic …See details»
Scorpion Therapeutics and Pierre Fabre Laboratories Announce …
For more information, visit scorpiontx.com. About Pierre Fabre Laboratories. Pierre Fabre Laboratories is a leading French medical and beauty care company with over 4 decades of …See details»
Scorpion Therapeutics to Present Preclinical Data for Potential Best …
Nov 21, 2022 For more information, visit www.scorpiontx.com. 1 American Cancer Society, The Cancer Genome Atlas Contacts. Media Contact: Ravi Moorthy Scorpion Therapeutics …See details»
Scorpion Therapeutics Launches With $108 Million To Advance …
The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s …See details»
Scorpion Therapeutics Presents Initial Clinical Data ... - Business Wire
Sep 15, 2024 “Scorpion is dedicated to bringing highly-selective small molecules to cancer patients as quickly as possible, and the presentation of these data is a testament to the team’s …See details»